美国FDA药品数据库(U.S. FDA Drugs Database)
检索条件: 药品名称=LOXITANE
符合检索条件的记录共9
1 页 当前第 1 页  返回检索页
1药品名称LOXITANE
申请号017525产品号001
活性成分LOXAPINE SUCCINATE市场状态停止上市
剂型或给药途径CAPSULE;ORAL规格EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
治疗等效代码参比药物
批准日期Approved Prior to Jan 1, 1982申请机构ACTAVIS LABORATORIES UT INC
2药品名称LOXITANE
申请号017525产品号002
活性成分LOXAPINE SUCCINATE市场状态停止上市
剂型或给药途径CAPSULE;ORAL规格EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
治疗等效代码参比药物
批准日期Approved Prior to Jan 1, 1982申请机构ACTAVIS LABORATORIES UT INC
3药品名称LOXITANE
申请号017525产品号003
活性成分LOXAPINE SUCCINATE市场状态停止上市
剂型或给药途径CAPSULE;ORAL规格EQ 25MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
治疗等效代码参比药物
批准日期Approved Prior to Jan 1, 1982申请机构ACTAVIS LABORATORIES UT INC
4药品名称LOXITANE
申请号017525产品号004
活性成分LOXAPINE SUCCINATE市场状态停止上市
剂型或给药途径CAPSULE;ORAL规格EQ 50MG BASE *Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
治疗等效代码参比药物
批准日期Approved Prior to Jan 1, 1982申请机构ACTAVIS LABORATORIES UT INC
5药品名称LOXITANE
申请号017525产品号006
活性成分LOXAPINE SUCCINATE市场状态停止上市
剂型或给药途径TABLET;ORAL规格EQ 10MG BASE **Federal Register determination that product was discontinued or withdrawn for s or e reasons**
治疗等效代码参比药物
批准日期Approved Prior to Jan 1, 1982申请机构ACTAVIS LABORATORIES UT INC
6药品名称LOXITANE
申请号017525产品号007
活性成分LOXAPINE SUCCINATE市场状态停止上市
剂型或给药途径TABLET;ORAL规格EQ 25MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
治疗等效代码参比药物
批准日期Approved Prior to Jan 1, 1982申请机构ACTAVIS LABORATORIES UT INC
7药品名称LOXITANE
申请号017525产品号008
活性成分LOXAPINE SUCCINATE市场状态停止上市
剂型或给药途径TABLET;ORAL规格EQ 50MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
治疗等效代码参比药物
批准日期Approved Prior to Jan 1, 1982申请机构ACTAVIS LABORATORIES UT INC
8药品名称LOXITANE C
申请号017658产品号001
活性成分LOXAPINE HYDROCHLORIDE市场状态停止上市
剂型或给药途径CONCENTRATE;ORAL规格EQ 25MG BASE/ML
治疗等效代码参比药物
批准日期Approved Prior to Jan 1, 1982申请机构ACTAVIS LABORATORIES UT INC
9药品名称LOXITANE IM
申请号018039产品号001
活性成分LOXAPINE HYDROCHLORIDE市场状态停止上市
剂型或给药途径INJECTABLE;INJECTION规格EQ 50MG BASE/ML
治疗等效代码参比药物
批准日期Approved Prior to Jan 1, 1982申请机构ACTAVIS LABORATORIES UT INC